Features of the blood coagulation system status in patients with uterine fibroids: a literature review
- Authors: Ozolinya L.A.1, Belousova A.O.1, Useinova S.E.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Issue: Vol 9, No 2 (2022)
- Pages: 83-92
- Section: Literature reviews
- URL: https://journals.rcsi.science/2313-8726/article/view/109098
- DOI: https://doi.org/10.17816/2313-8726-2022-9-2-83-92
- ID: 109098
Cite item
Full Text
Abstract
Currently, uterine fibroids are one of the most common gynecological diseases, with surgical treatments provided in many cases, but hormone therapy is widely used. Gynecologists must consider all aspects of the patient’s condition during treatment, including the blood coagulation system status. Features of hemostasis affect the disease development, features and outcomes of the operation, and the postoperative period course, as well as the possibility of carrying out the necessary drug therapy and its results. This literature review reflects the results of research by domestic and foreign authors regarding the hemostasis system status in patients with uterine fibroids, including the effect of hormonal, antioxidant, and disaggregate therapy. The studies conducted allowed the authors to predict the possibility of bleeding and thromboembolic complications in patients, as well as the growth of uterine fibroids, to timely correct hemostasis and improve the treatment results in patients with this pathology.
Full Text
##article.viewOnOriginalSite##About the authors
Lyudmila A. Ozolinya
N.I. Pirogov Russian National Research Medical University
Author for correspondence.
Email: ozolinya@yandex.ru
ORCID iD: 0000-0002-2353-123X
SPIN-code: 9407-9014
M.D., Dr. Sci. (Med.), Professor, Professor of the Department of Obstetrics and Gynecology
Russian Federation, 1 Ostrovityanova str., Moscow, 117997Alina O. Belousova
N.I. Pirogov Russian National Research Medical University
Email: belousova_ao@mail.ru
ORCID iD: 0000-0002-1348-6754
V-year student
Russian Federation, 1 Ostrovityanova str., Moscow, 117997Sofiya E. Useinova
N.I. Pirogov Russian National Research Medical University
Email: sofa_useinova00@mail.ru
ORCID iD: 0000-0002-6511-8734
V-year student
Russian Federation, 1 Ostrovityanova str., Moscow, 117997References
- Vinokurova EA. Hemostasis in patients with uterine fibroids. Advances in Current Natural Sciences. 2004;(12):38–39. (In Russ).
- Khvorostukhina NF, Ostrovskaya AE, Rogozhina IE, Novichkov DA, Stepanova NN. Features of uterine hemodynamics and hemostasis system in fibroids complicated by hemorrhagic syndrome. Obstetrics and Gynecology. 2016;(9):87–93. (In Russ). doi: 10.18565/aig.2016.6.87-93
- Aimagambetova GN. Research of hemostasis at patients with hysteromyoma in combination with anemia. Vestnik NSU. Seriya: Biologiya, klinicheskaya meditsina. 2007;5(3):3–6. (In Russ).
- Rogozhina IE, Khvorostukhina NF. Lowinvasive Technologies and Hemostasis System at a Hysteromyoma. Saratov Journal of Medical Scientific Research. 2011;7(3):587–592. (In Russ).
- Oslopov VN, Sadykova AR, Akhmetzyanova EF, et al. Difficulties in diagnosis of pulmonary embolism at the patient with gigantic myoma of uterus. Meditsinskaya praktika. 2010;(5):136–138. (In Russ).
- Sukhikh GT, Kirienko AI, Dolgushina NV, et al.; National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, I.M. Sechenov First Moscow State Medical University, N.I. Pirogov Russian National Research Medical University, et al. Prevention of Venous Thromboembolic Complications in Obstetrics and Gynecology. Clinical Recommendations (Protocol). Moscow, 2014. 32 p. Available from: https://mosgorzdrav.ru/uploads/imperavi/ru-RU/025_2014.pdf. (In Russ).
- Sharafutdinov BM, Antropova EYu, Abdul’yanov IV, et al. Coronary heart disease and uterine fibroids: case history. Russian Medical Journal. 2020;(6):34–37. (In Russ).
- Tarabrin OA, Galich SR, Gavrichenko DG, et al. Diagnosis, prevention and complex correction of activation of fibrinolytic component of hemostatic system in patients with hysteromyoma. Meditsina Neotlozhnykh Sostoyanii. 2012;(7–8):46–47. (In Russ).
- Yaskevich NN. Narusheniya gemostaza pri rake i miome matki, ikh korrektsiya vitaminami-antioksidantami [dissertation]. Tyumen’; 2009. 149 p. Available from: https://elibrary.ru/item.asp?id=16198580. (In Russ).
- Ozolinya LA, Kerchelaeva SB, Lapina IA, Makarov OV. Venous Thromboembolic Complications in Obstetrics and Gynecology. 2nd edition, correct. and suppl. Moscow: GEOTAR-Media; 2020. 288 p. (In Russ). doi: 10.33029/9704-5651-4-VTO-2020-1-288
- Patent RUS № RU 2 592 374 C2/ 20.07.2016. Byul. № 20. Spiridonova NV, Basina EI, Klykova OV, Shchukin VYu. Sposob prognozirovaniya razvitiya krovotechenii u zhenshchin s miomoi matki. Available from: https://patenton.ru/patent/RU2592374C2. (In Russ).
- Patent RUS № RU 2 704 819 C1/ 09.07.2019. Byul. № 31. Voskresenskaya DL, Voronin DN, Antsiferova YuS, Sotnikova NYu, Malyshkina AI. A method for predicting an increase in the size of uterine leiomyoma. Available from: https://patents.s3.yandex.net/RU2704819C1_20191031.pdf. (In Russ).
- Pestrikova TYu, Yurasova EA, Yurasov IV, Chirkov AV. Rational choice of tactics in patients with uterine fibroids. Gynecology. 2017;19(5):15–19. (In Russ). doi: 10.26442/2079-5696_19.5.15-19
- Nasiadek M, Kilanowicz A, Darago A, Lazarenkow A, Michalska M. The effect of cadmium on the coagulation and fibrinolytic system in women with uterine endometrial cancer and myoma. Int J Occup Med Environ Health. 2013;26(2):291–301. doi: 10.2478/s13382-013-0089-z
- Klykova OV. Kliniko-immunologicheskie osobennosti miomy matki, trebuyushchei khirurgicheskogo lecheniya v reproduktivnom vozraste [dissertation]. Samara; 2018. 133 p. Available from: https://samsmu.ru/files/referats/2018/klykova/dissertation.pdf. (In Russ).
- Khokhlova RR. Optimizatsiya perioperatsionnoi profilaktiki oslozhnenii pri miomektomii u zhenshchin, planiruyushchikh beremennost’ [dissertation]. Volgograd; 2020. 158 p. Available from: 9-935-1594039225_hohlova_regina_robertovna.pdf. (In Russ).
- Patent RUS № RU 2 690 379 C1/ 03.06.2019. Byul. № 16. Pogorelova TN, Gun’ko VO, Ermolova NV, et al. Sposob prognozirovaniya tempov rosta leiomiomy matki u zhenshchin reproduktivnogo vozrasta. Available from: https://patenton.ru/patent/RU2690379C1 (In Russ).
- Patent RUS № RU 02361216 C1/ 10.07.2009. Byul. № 19. Sotnikova NYu, Posiseeva LV, Boiko OM, Antsiferova YuS, Malyshkina AI. Sposob differentsial’noi diagnostiki tipa rosta leiomiomy matki. Available from: https://rusneb.ru/catalog/000224_000128_0002361216_20090710_C1_RU/. (In Russ).
- Patent RUS № RU 2 542 468 С1/ 20.02.2015. Byul. № 5. Malyshkina AI, Sotnikova NYu, Peretyatko LP, Voronin DN, Litsova AO. Sposob differentsial’noi diagnostiki tipov rosta leiomiomy matki. Available from: https://rusneb.ru/catalog/000224_000128_0002542468_20150220_C1_RU/. (In Russ).
- Adamyan LV, Andreeva EN, Artymuk NV, et al.; Russian Society of Obstetricians and Gynecologists; National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, et al. Uterine Fibroids: Diagnosis, Treatment and Rehabilitation. Clinical Recommendations (Treatment Protocol). Moscow; 2015. 74 p. Available from: https://docs.cntd.ru/document/456019539. (In Russ).
Supplementary files
